The Biophysics Research Program at ETSU

 

 

 

Hypoxia-Selective Modification of Radiation Damage to DNA

 

                                                                             

DNA has long been recognized as a principal target for ionizing radiation in cells at low doses. Many of the chemical alterations produced by radiation in DNA, if not repaired, result in cell death. The lethal effect of radiation on tumor cells is widely used in radiation cancer treatment. This emphasizes the importance of selective targeting of DNA in these cells since it reduces the overall dose needed to kill the cell.

 

One of the basic problems associated with radiation cancer treatment is the selective targeting of tumors. The microenvironment of solid tumors has several specific features that distinguish them from that of surrounding normal tissues. One of the most pronounced of them is the tumor hypoxia (reduced oxygenation level) originating from relatively poor vascularization.. Hypoxia decreases radiosensitivity of tumor cells up to 3-fold as compared to well-oxygenated cells, which is an unfavorable situation from the viewpoint of radiation cancer treatment. There is no question nowadays that the treatment outcome, i.e. tumor survival is directly related to its oxygenation level. On the other hand, hypoxia is not only a problem, but also a feature that makes tumor tissues distinguishable from normal ones.  This underscores the importance of understanding the mechanisms of radiation-induced DNA damage and of development of the chemical modifiers capable of enhancing radiation damage to cellular DNA selectively in hypoxic areas.

 

My research is aimed at the development of hypoxia-selective agents for directional modification of DNA upon activation with ionizing radiation. The term “directional” includes both the predictable structure of the generated lesion, and its localization in the target DNA. Specifically, the project focuses on the mechanisms and sequence-specificity of DNA damage by several prospective DNA cleaving agents and their conjugates with established DNA-recognizing entities.

 

 

 

Pictures of Yuri’s Lab

 

 

 

Cary 100 Bio Spectrophotometer

 

 

 

 

Waters Associates HPLC

 

 

 

 

 

 

Back to Physics Homepage

Last modified June 11, 2003  by  Alexis Close